📰 Efficacy Registry News

Efficacy Registry News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Efficacy Registry. Real-time updates on events, politics, business and more.

GI symptoms in systemic scleroderma unrelated to disease-specific medications

November 30, 2022

New research presented this week at ACR Convergence 2022, the American College of Rheumatologys annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and...

United States Los Angeles Sarah Luebker University Of California Vanderbilt University Medical Center Collaborative National Quality

Source: medicaldialogues.in

Immunosuppressive, anti-fibrotic drugs not tied to worsening GI symptoms in early SSc

November 12, 2022

PHILADELPHIA &mdash; Immunosuppressive or anti-fibrotic drugs do not appear to have any clear impact on worsening gastrointestinal symptoms in patients with early systemic sclerosis, according to data presented at ACR Convergence 2022.

United States Sarah Luebker Robert Stott Vanderbilt University Medical Center Collaborative National Quality Efficacy Registry

Source: healio.com

Study Finds Gastrointestinal Symptoms in Systemic Scleroderma Unrelated to Disease-Specific Medications

November 9, 2022

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosupp

United States Los Angeles Sarah Luebker Ssc Centers Of Excellence University Of California Vanderbilt University Medical Center

Source: newswise.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Efficacy Registry News Today

GI symptoms in systemic scleroderma unrelated to disease-specific medications

Immunosuppressive, anti-fibrotic drugs not tied to worsening GI symptoms in early SSc

Study Finds Gastrointestinal Symptoms in Systemic Scleroderma Unrelated to Disease-Specific Medications

Explore More Categories